Systemic lupus: initial tests and laboratory monitoring in the community
BioMG follows French guidelines. Adapt it to the guidelines and the tests available where you practise.
Suspected or recently diagnosed lupus: initial tests
Fasting laboratory tests (state the clinical context on the request form)
- Antinuclear antibodies (titre and pattern)
- Anti-dsDNA antibodies
- Anti-ENA antibodies (including anti-Sm, anti-SSA, anti-SSB, anti-RNP)
- Complement: CH50, C3 and C4
- FBC
- Serum creatinine with eGFR
- Serum protein electrophoresis
- CRP
- Antiphospholipid antibodies: lupus anticoagulant, anticardiolipin IgG and IgM, anti-beta-2-glycoprotein I IgG and IgM
- Reticulocyte countif neededThe PNDS asks for a blood count with reticulocytes and a direct antiglobulin test, looking in particular for haemolytic anaemia [1].
- Direct Coombs testif neededThe PNDS asks for a blood count with reticulocytes and a direct antiglobulin test, looking in particular for haemolytic anaemia [1].
- TSHif neededAutoimmune thyroiditis (most often Hashimoto's) is a disease associated with lupus, sought depending on the context [1].
- Anti-TPO antibodiesif neededAutoimmune thyroiditis (most often Hashimoto's) is a disease associated with lupus, sought depending on the context [1].
- HIV, hepatitis C and parvovirus B19 IgG and IgM serology (if early presentation that may be viral)if neededThe PNDS suggests them to exclude a viral infection that sometimes mimics lupus at onset [1].
- Hepatitis B serology (before corticosteroids at immunosuppressive dose, immunosuppressant or biologic therapy)if neededBefore corticosteroids at immunosuppressive dose, an immunosuppressant or a biologic therapy: HIV, hepatitis C and hepatitis B serologies (HBsAg, anti-HBs, anti-HBc) [1].
- Fasting plasma glucoseif neededTests before corticosteroids suggested by the PNDS: fasting plasma glucose, lipid profile, serum electrolytes [1].
- Lipid profileif neededTests before corticosteroids suggested by the PNDS: fasting plasma glucose, lipid profile, serum electrolytes [1].
- Serum electrolytesif neededTests before corticosteroids suggested by the PNDS: fasting plasma glucose, lipid profile, serum electrolytes [1].
- Serum β-hCG (if woman of childbearing potential, before treatment)if neededThe pregnancy test is among the tests that prepare for treatment; effective contraception is essential on teratogenic treatment [1].
Urine tests
- Urine dipstick (proteinuria, haematuria, leucocyturia)
- Urine protein:creatinine ratio (spot sample)
- Urine microscopy and culture (if haematuria or leucocyturia on dipstick)if neededThe PNDS asks for examination of the urinary sediment (urine microscopy and culture): haematuria, leucocyturia, casts [1].
Do not order
- Anti-denatured DNA antibodies and IgM-isotype anti-dsDNA antibodies: no diagnostic value [1].
- Anti-nucleosome, anti-ribosomal P protein, anti-Ku, anti-C1q antibodies as a routine: not to be tested for from the outset [1].
- Interferon alpha assay or “interferon signature”: not in routine practice to establish the diagnosis [1].
Known, stable lupus: laboratory monitoring (every 3 to 6 months)
Every 3 to 6 months
- Urine dipstick (proteinuria; if positive, haematuria)
- Urine protein:creatinine ratio (spot sample) (if the dipstick is positive)if neededProteinuria on dipstick is quantified by the spot-sample urine protein:creatinine ratio or 24-hour urine protein [1].
- FBC
- Serum creatinine with eGFR
- AST
- ALT
- Alkaline phosphatase
- Complement C3 (and C4)
Every 6 to 12 months
- Anti-dsDNA antibodies
Once a year (if corticosteroids or other risk factor)
- Fasting plasma glucoseif neededGlucose and lipid tests once a year on corticosteroids, tacrolimus or another risk factor, otherwise according to the general-population recommendations [1].
- Lipid profileif neededGlucose and lipid tests once a year on corticosteroids, tacrolimus or another risk factor, otherwise according to the general-population recommendations [1].
Depending on the context
- Blood hydroxychloroquine (if flare or doubt about adherence; not reimbursed in France for outpatients)if neededThe blood assay helps adjust the dose and assess adherence; the risk of relapse increases below 750 ng/mL [1]. It is not reimbursed in community laboratories in France [1].
- 25-hydroxyvitamin D (if deficiency suspected, for example sun avoidance or corticosteroid treatment)if needednon-French guidelineThe BSR (2026) recommends daily vitamin D supplementation for everyone all year round, especially in autumn and winter (strong recommendation, level B), and, when judged useful, a level to reinforce supplementation if it is low (level C) [4]. The PNDS lists vitamin D deficiency, favoured by sun avoidance, among the risk factors for osteoporosis in lupus, together with corticosteroid therapy [1]; the NABM does not cover this test for this indication [6].
- Hepatitis B serologyif neededScreening for viral infections in case of an immunosuppressant or a biologic therapy [1].
- Hepatitis C serologyif neededScreening for viral infections in case of an immunosuppressant or a biologic therapy [1].
- HIV serologyif neededScreening for viral infections in case of an immunosuppressant or a biologic therapy [1].
Also consider
- Cervical screening up to date? In women with lupus, cervical screening is more frequent; see the page "Dépistage du cancer du col".
Do not order
Known lupus: pregnancy planning and pregnancy
Before pregnancy (preconception visit)
- Antiphospholipid antibodies: lupus anticoagulant, anticardiolipin IgG and IgM, anti-beta-2-glycoprotein I IgG and IgM (if not done or old)
- Anti-SSA and anti-SSB antibodies (if not known)
- Serum creatinine with eGFR
- Urine protein:creatinine ratio (spot sample)
- Rubella serology (if immunity unknown)if neededThe preconception visit checks immunity to rubella, to vaccinate if needed in the absence of contraindication [1].
During pregnancy: every month
- Serum creatinine with eGFR
- Urine protein:creatinine ratio (spot sample)
- Complement C3 and C4
- Anti-dsDNA antibodies
- AST
- ALT
- FBC (haemoglobin, platelets)
- Plasma glucose
- Toxoplasmosis serologyif neededThe PNDS includes them in monthly monitoring if they are negative [1].
- Rubella serologyif neededThe PNDS includes them in monthly monitoring if they are negative [1].
- Urine dipstick and blood pressure at every visit (pre-eclampsia, renal flare).
Sources (7)
- Centre de référence du lupus, SAPL et autres maladies auto-immunes rares ; centre de référence RAISE ; filière FAI²R. Protocole national de diagnostic et de soins (PNDS) : lupus systémique de l'adulte et de l'enfant. Haute Autorité de santé, janvier 2024 (mis en ligne le 9 février 2024).
- Centre de référence du lupus, SAPL et autres maladies auto-immunes rares ; filière FAI²R. Lupus systémique de l'adulte et de l'enfant : synthèse à destination du médecin traitant, extraite du PNDS. Haute Autorité de santé, janvier 2024.
- Assurance maladie. Nomenclature des actes de biologie médicale (NABM), version 105 : sous-chapitre 7-03 auto-immunité (actes 1453 à 1461) et acte 1020 (anticoagulant de type lupique) ; aucun acte pour l'anti-bêta-2-glycoprotéine I ni pour le dosage sanguin d'hydroxychloroquine.
- Md Yusof MY, Smith EMD, Lythgoe H, et al. The 2026 British Society for Rheumatology guideline for the management of children, young people and adults with systemic lupus erythematosus. Rheumatology (Oxford). 2026;65(6):keag223.
- Lam NV, Brown JA, Sharma R. Systemic Lupus Erythematosus: Diagnosis and Treatment. Am Fam Physician. 2023;107(4):383-395.
- Assurance maladie. Nomenclature des actes de biologie médicale (NABM), version 105 : acte 1139 (25-OH-vitamine D), conditions de prise en charge ; aucun acte actif pour la vitesse de sédimentation.
- Collège français des enseignants en rhumatologie (COFER). Item 192 : Pathologies auto-immunes : aspects épidémiologiques, diagnostiques et principes de traitement. Référentiel en ligne du Collège (lecofer.org), consulté le 11 octobre 2026.